Arcellx

Arcellx Goodwill/Assets

Delisted

Goodwill to Total Assets Ratio of Arcellx (ACLX) as of Oct 18, 2026.

Goodwill/Assets

0.00

Last updated:

Goodwill to Total Assets Ratio of Arcellx is 2025 0.00 . Goodwill to Total Assets Ratio of Arcellx was 2024 0.00 . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Arcellx Stock analysis

What does Arcellx do? Arcellx Inc, headquartered in Gaithersburg, US, is a clinical-stage biotechnology company focused on developing innovative cell therapies for cancer and other incurable diseases. The company, listed on February 4, 2022, operates with 209 employees and is advancing its lead program CART-ddBCMA in a pivotal Phase II trial for relapsed or refractory multiple myeloma. It also develops two clinical-stage ARC-SparX programs targeting BCMA and CD123 in various hematological malignancies. Arcellx is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Arcellx stock

On Eulerpool you can find the complete historical development of Goodwill to Total Assets Ratio Arcellx since 2006 – with annual values, charts, and detailed analysis.

The Goodwill/Assets ratio shows what percentage of total assets consists of acquisition goodwill. High ratios may indicate impairment risk.

Goodwill to Total Assets Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Goodwill to Total Assets Ratio's Arcellx historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Arcellx

All Key Metrics — Arcellx